Find clinical trials for Alzheimer's Disease in Hanyang, Seoul
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Alzheimer's Disease trials near Hanyang, Seoul, KOR:
efficacy of the Focused ultrasound stimulator system (NMS-01) for transient Blood-Brain Barrier (BBB) opening in patients with mild to moderate Alzheimer's...
Seoul, Seodaemun, South Korea
To evaluate the safety and efficacy of PM012 tablets for Alzheimer's disease, dose-finding study will be performed on phase 2b, and...
Phase 2, Phase 3
Seoul, Seongdon-gu, Korea, Republic of
This is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in p...
Phase 2
Seoul, South Korea and 71 other locations
The goal of this clinical trial is to evaluate safety and potential therapeutic effect of intraveneously administered CB-AC-02 in patients with Alzheimer's...
Phase 1, Phase 2
Seongnam-si, Gyeonggi-do, Korea, Republic of
of KDS2010 in patients with Mild Cognitive Impairment (MCI) due to Alzheimer's disease (AD) and mild dementia due to Alzheimer's...
Phase 2
Seoul, Seoul, South Korea and 7 other locations
The study medicine GSK4527226 is being studied in participants with Alzheimer's Disease (AD) in study 219867 (the parent study, NCT...
Phase 2
Junggu, South Korea and 32 other locations
This 52-week, open-label extension study is to evaluate the long-term safety and tolerability of ACP-204 in subjects with ADP.
Phase 3
Seoul, South Korea and 76 other locations
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease...
Phase 3
Seoul, Seoul-teukbyeolsi [Seoul], South Korea and 117 other locations
This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies...
Phase 2, Phase 3
Seoul, South Korea and 152 other locations
This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determin...
Phase 3
Seoul, South Korea and 249 other locations
Clinical trials
Research sites
Resources
Legal